{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T18:58:50Z","timestamp":1774292330573,"version":"3.50.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["72374052"],"award-info":[{"award-number":["72374052"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China,China","doi-asserted-by":"crossref","award":["72274045"],"award-info":[{"award-number":["72274045"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"China National Health Development Research Center Project","award":["CNHDRC-KJ-W-2023-27"],"award-info":[{"award-number":["CNHDRC-KJ-W-2023-27"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Econ Rev"],"DOI":"10.1186\/s13561-026-00745-9","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:46:42Z","timestamp":1771055202000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Economic evaluation of national immunization program vaccines in China: a systematic review"],"prefix":"10.1186","volume":"16","author":[{"given":"Jiannan","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haofei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling Jie","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuzhi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiemin","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"issue":"43","key":"745_CR1","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.15585\/mmwr.mm7243a1","volume":"72","author":"G Kaur","year":"2023","unstructured":"Kaur G, Danovaro-Holliday MC, Mwinnyaa G, Gacic-Dobo M, Francis L, Grevendonk J, Sodha SV, Sugerman C, Wallace A. Routine vaccination Coverage - Worldwide, 2022. MMWR Morbidity Mortal Wkly Rep. 2023;72(43):1155\u201361.","journal-title":"MMWR Morbidity Mortal Wkly Rep"},{"issue":"7781","key":"745_CR2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41586-019-1656-7","volume":"575","author":"P Piot","year":"2019","unstructured":"Piot P, Larson HJ, O\u2019Brien KL, N\u2019Kengasong J, Ng E, Sow S, Kampmann B. Immunization: vital progress, unfinished agenda. Nature. 2019;575(7781):119\u201329.","journal-title":"Nature"},{"issue":"7\u20138","key":"745_CR3","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/S0264-410X(02)00623-0","volume":"21","author":"J Ehreth","year":"2003","unstructured":"Ehreth J. The global value of vaccination. Vaccine. 2003;21(7\u20138):596\u2013600.","journal-title":"Vaccine"},{"key":"745_CR4","unstructured":"World Health Assembly (27th. 1974): The Expanded Programme on Immunization: the 1974 Resolution by the World Health Assembly. Assignment children 1985, 69\u201372:87\u201388."},{"issue":"10441","key":"745_CR5","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1016\/S0140-6736(24)00850-X","volume":"403","author":"AJ Shattock","year":"2024","unstructured":"Shattock AJ, Johnson HC, Sim SY, Carter A, Lambach P, Hutubessy RCW, Thompson KM, Badizadegan K, Lambert B, Ferrari MJ, et al. Contribution of vaccination to improved survival and health: modelling 50 years of the expanded programme on immunization. Lancet (London England). 2024;403(10441):2307\u201316.","journal-title":"Lancet (London England)"},{"issue":"3","key":"745_CR6","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2471\/BLT.18.219469","volume":"97","author":"J Liu","year":"2019","unstructured":"Liu J, Liang W, Jing W, Liu M. Countdown to 2030: eliminating hepatitis B disease, China. Bull World Health Organ. 2019;97(3):230\u20138.","journal-title":"Bull World Health Organ"},{"issue":"6","key":"745_CR7","first-page":"878","volume":"56","author":"GJ Wang","year":"2022","unstructured":"Wang GJ, Shao ML. [Analysis of the development status and trend of vaccines in china\u2019s immunization program in the past decade]. Chin J Prev Med. 2022;56(6):878\u201383.","journal-title":"Chin J Prev Med"},{"issue":"5","key":"745_CR8","doi-asserted-by":"publisher","first-page":"e28782","DOI":"10.1002\/jmv.28782","volume":"95","author":"X Zhang","year":"2023","unstructured":"Zhang X, Jin N, Tu A, Dong M, Shi T, Ren X, Liu S, Zhao X, Liu J, Wu Z, et al. Adults in Northwest China experienced the largest outbreak of Japanese encephalitis in history 10 years after the Japanese encephalitis vaccine was included in the National immunization program: A retrospective epidemiological study. J Med Virol. 2023;95(5):e28782.","journal-title":"J Med Virol"},{"key":"745_CR9","doi-asserted-by":"publisher","first-page":"e53982","DOI":"10.2196\/53982","volume":"10","author":"BW Ming","year":"2024","unstructured":"Ming BW, Li L, Huang HN, Ma JJ, Shi C, Xu XH, Yang Z, Ou CQ. The effectiveness of National expanded program on immunization with hepatitis A vaccines in the Chinese mainland: interrupted Time-Series analysis. JMIR Public Health Surveillance. 2024;10:e53982.","journal-title":"JMIR Public Health Surveillance"},{"issue":"2","key":"745_CR10","first-page":"100113","volume":"2","author":"J Pan","year":"2021","unstructured":"Pan J, Wang Y, Cao L, Wang Y, Zhao Q, Tang S, Gong W, Guo L, Liu Z, Wen Z, et al. Impact of immunization programs on 11 childhood vaccine-preventable diseases in china: 1950\u20132018. Innov (Cambridge (Mass). 2021;2(2):100113.","journal-title":"Innov (Cambridge (Mass)"},{"key":"745_CR11","doi-asserted-by":"publisher","first-page":"e1045","DOI":"10.1016\/S2468-2667(25)00039-8","volume":"10","author":"C Wang","year":"2025","unstructured":"Wang C, Lai X, Abbas K, Pouwels KB, Zhang H, Jit M, Fang H. Health impact and economic evaluation of the expanded program on immunization in China from 1974 to 2024: a modelling study. Lancet Public Health. 2025;10(12):e1045-e1054.","journal-title":"Lancet Public Health"},{"issue":"12","key":"745_CR12","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1136\/gutjnl-2023-330691","volume":"72","author":"Z Liu","year":"2023","unstructured":"Liu Z, Lin C, Mao X, Guo C, Suo C, Zhu D, Jiang W, Li Y, Fan J, Song C, et al. Changing prevalence of chronic hepatitis B virus infection in China between 1973 and 2021: a systematic literature review and meta-analysis of 3740 studies and 231 million people. Gut. 2023;72(12):2354\u201363.","journal-title":"Gut"},{"issue":"8","key":"745_CR13","doi-asserted-by":"publisher","first-page":"e3015","DOI":"10.1371\/journal.pntd.0003015","volume":"8","author":"X Gao","year":"2014","unstructured":"Gao X, Li X, Li M, Fu S, Wang H, Lu Z, Cao Y, He Y, Zhu W, Zhang T, et al. Vaccine strategies for the control and prevention of Japanese encephalitis in Mainland China, 1951\u20132011. PLoS Negl Trop Dis. 2014;8(8):e3015.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"745_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12879-023-08194-z","volume":"23","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Lin S, Dong S, Zhang C, Shi L, Ren X, Li Z, Wang L, Fang L. Incidence and trends of 17 notifiable bacterial infectious diseases in China, 2004\u20132019. BMC Infect Dis. 2023;23(1):273.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"745_CR15","doi-asserted-by":"publisher","first-page":"e1016","DOI":"10.1016\/S2468-2667(23)00248-7","volume":"8","author":"H Zhang","year":"2023","unstructured":"Zhang H, Lai X, Patenaude BN, Jit M, Fang H. Adding new childhood vaccines to china\u2019s National immunization program: evidence, benefits, and priorities. Lancet Public Health. 2023;8(12):e1016\u201324.","journal-title":"Lancet Public Health"},{"issue":"1","key":"745_CR16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s40249-023-01150-8","volume":"12","author":"M Jiang","year":"2023","unstructured":"Jiang M, Chen S, Yan X, Ying X, Tang S. The coverage and challenges of increasing uptake of non-National immunization program vaccines in china: a scoping review. Infect Dis Poverty. 2023;12(1):114.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"745_CR17","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1186\/s12889-024-21013-7","volume":"24","author":"J Guo","year":"2024","unstructured":"Guo J, Zheng B, Chen T, Guo S, Liu M, Dong S. Prioritizing vaccine introduction to china\u2019s National immunization program: a multi-criteria decision analysis. BMC Public Health. 2024;24(1):3458.","journal-title":"BMC Public Health"},{"issue":"12","key":"745_CR18","doi-asserted-by":"publisher","first-page":"e1064","DOI":"10.1016\/S2468-2667(22)00171-2","volume":"7","author":"S Chen","year":"2022","unstructured":"Chen S, Yao L, Wang W, Tang S. Developing an effective and sustainable National immunisation programme in china: issues and challenges. Lancet Public Health. 2022;7(12):e1064\u201372.","journal-title":"Lancet Public Health"},{"issue":"1","key":"745_CR19","doi-asserted-by":"publisher","first-page":"2194190","DOI":"10.1080\/21645515.2023.2194190","volume":"19","author":"P Dai","year":"2023","unstructured":"Dai P, Wang Q, Jia M, Leng Z, Xie S, Feng L, Yang W. Driving more WHO-recommended vaccines in the National immunization program: issues and challenges in China. Hum Vaccines Immunotherapeutics. 2023;19(1):2194190.","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"3","key":"745_CR20","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1086\/341419","volume":"35","author":"SM Ess","year":"2002","unstructured":"Ess SM, Szucs TD. Economic evaluation of immunization strategies. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2002;35(3):294\u20137.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"issue":"1","key":"745_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12916-021-02049-7","volume":"19","author":"H Zhang","year":"2021","unstructured":"Zhang H, Garcia C, Yu W, Knoll MD, Lai X, Xu T, Jing R, Qin Y, Yin Z, Wahl B, et al. National and provincial impact and cost-effectiveness of haemophilus influenzae type b conjugate vaccine in china: a modeling analysis. BMC Med. 2021;19(1):181.","journal-title":"BMC Med"},{"key":"745_CR22","first-page":"n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical Res ed). 2021;372:n71.","journal-title":"BMJ (Clinical Res ed)"},{"issue":"1","key":"745_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jval.2021.10.008","volume":"25","author":"D Husereau","year":"2022","unstructured":"Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, Caulley L, Chaiyakunapruk N, Greenberg D, Loder E, et al. Consolidated health economic evaluation reporting standards (CHEERS) 2022 explanation and elaboration: A report of the ISPOR CHEERS II good practices task force. Value Health: J Int Soc Pharmacoeconomics Outcomes Res. 2022;25(1):10\u201331.","journal-title":"Value Health: J Int Soc Pharmacoeconomics Outcomes Res"},{"issue":"1","key":"745_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.18553\/jmcp.2003.9.1.86","volume":"9","author":"B Motheral","year":"2003","unstructured":"Motheral B. Assessing the value of the quality of health economic studies (QHES). J Managed Care Pharmacy: JMCP. 2003;9(1):86\u20137.","journal-title":"J Managed Care Pharmacy: JMCP"},{"issue":"4","key":"745_CR25","first-page":"369","volume":"23","author":"L Zhang","year":"2017","unstructured":"Zhang L, Jiang F, Guan Q. Cost\u2013benefit evaluation of meningococcal polysaccharide vaccination in Guizhou Province. Chin J Vaccines Immun. 2017;23(4):369\u201374. [in Chinese].","journal-title":"Chin J Vaccines Immun"},{"issue":"1","key":"745_CR26","first-page":"80","volume":"31","author":"B Lin","year":"2025","unstructured":"Lin B, Li M, Zhang Q, Yan T, Wu D, Zhou J, Zheng H. Cost\u2013utility analysis of meningococcal polysaccharide vaccination in the National immunization program of China. Chin J Vaccines Immun. 2025;31(1):80\u20136. [in Chinese].","journal-title":"Chin J Vaccines Immun"},{"issue":"8","key":"745_CR27","first-page":"755","volume":"37","author":"X Li","year":"2021","unstructured":"Li X, Jia M, Li H, Zhang J, Li P, Wang Z. Economic evaluation on vaccination against hemorrhagic fever with renal syndrome in Baoji. Med Anim Control. 2021;37(8):755\u20137. [in Chinese].","journal-title":"Med Anim Control"},{"issue":"7","key":"745_CR28","first-page":"62","volume":"32","author":"J Zhang","year":"2013","unstructured":"Zhang J, Zheng H, Liang J, Xia Y. Expanding immunization project by bringing attenuated hepatitis A vaccine into Guangdong Province. Chin Health Econ. 2013;32(7):62\u20135. [in Chinese].","journal-title":"Chin Health Econ"},{"key":"745_CR29","first-page":"5","volume":"3","author":"C Liu","year":"2012","unstructured":"Liu C. Economic evaluation of BCG vaccination for newborns in China. China Pharm Econ Manage. 2012;3:5. [in Chinese].","journal-title":"China Pharm Econ Manage"},{"issue":"23","key":"745_CR30","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1016\/j.vaccine.2019.04.057","volume":"37","author":"Y Zeng","year":"2019","unstructured":"Zeng Y, Luo M, Chen J, He H, Deng X, Xie S, Fang Y. An economic evaluation of the current measles vaccination program: A case study in Zhejiang Province, East China. Vaccine. 2019;37(23):3071\u20137.","journal-title":"Vaccine"},{"issue":"37","key":"745_CR31","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.1016\/j.vaccine.2012.05.068","volume":"30","author":"Z Yin","year":"2012","unstructured":"Yin Z, Beeler Asay GR, Zhang L, Li Y, Zuo S, Hutin YJ, Ning G, Sandhu HS, Cairns L, Luo H. An economic evaluation of the use of Japanese encephalitis vaccine in the expanded program of immunization of Guizhou province, China. Vaccine. 2012;30(37):5569\u201377.","journal-title":"Vaccine"},{"issue":"5","key":"745_CR32","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jval.2022.10.011","volume":"26","author":"D Wu","year":"2023","unstructured":"Wu D, Jing R, Zheng H, He K, Li Y, Yu W, Yin Z, Fang H. Health and economic evaluation of vaccination against pertussis in china: A 40-Year analysis. Value Health: J Int Soc Pharmacoeconomics Outcomes Res. 2023;26(5):666\u201375.","journal-title":"Value Health: J Int Soc Pharmacoeconomics Outcomes Res"},{"issue":"2","key":"745_CR33","first-page":"121","volume":"25","author":"Q Bai","year":"2019","unstructured":"Bai Q, Yuan S, Wang X, Wu J, Shi X. Benefit\u2013cost ratio of hepatitis B vaccination for preventing hepatitis B\u2013related cirrhosis in Beijing, 1992\u20132013. Chin J Vaccines Immun. 2019;25(2):121\u20135. [in Chinese].","journal-title":"Chin J Vaccines Immun"},{"key":"745_CR34","first-page":"47","volume":"9","author":"Y Qi","year":"2004","unstructured":"Qi Y, Gong X, Pan L, Zeng X, Li H. Analysis on cost\u2013benefit for infant hepatitis B vaccine immunization strategy in Beijing. Chin J Public Health. 2004;9:47\u20139. [in Chinese].","journal-title":"Chin J Public Health"},{"key":"745_CR35","first-page":"33","volume":"12","author":"L Gao","year":"2004","unstructured":"Gao L. The cost\u2013benefit analysis of the HBV vaccine plan immunity program of Dalian City. Prim Health Care China. 2004;12:33\u20135. [in Chinese].","journal-title":"Prim Health Care China"},{"key":"745_CR36","first-page":"58","volume":"5","author":"J Zhang","year":"2008","unstructured":"Zhang J, Zhao Z, Shao X, Liang J, Zou Y. Cost\u2013benefit analysis of hepatitis B vaccine inclusion in the immunization program in Guangdong Province over four years. South China J Prev Med. 2008;5:58\u201360. [in Chinese].","journal-title":"South China J Prev Med"},{"key":"745_CR37","unstructured":"Zhang H. Study on Disease Burden and Control Evaluation of Hepatitis B in Jiangsu Province. [dissertation\/master\u2019s thesis]. Nanjing, China: Southeast University. 2015. [in Chinese]."},{"key":"745_CR38","unstructured":"Yang S. Economic evaluation of infant hepatitis B vaccination in Ningbo City. [dissertation\/master\u2019s thesis]. Ningbo, China: Ningbo University. 2013. [in Chinese]."},{"issue":"11","key":"745_CR39","first-page":"1310","volume":"27","author":"W Miao","year":"2011","unstructured":"Miao W, Wang X, Liu X, Wang M, Bu J, Song Y. Cost\u2013benefit analysis of hepatitis B vaccination among children under 5 years old in Rizhao City. Occup Health. 2011;27(11):1310\u20131. [in Chinese].","journal-title":"Occup Health"},{"key":"745_CR40","unstructured":"L\u00fc J. Economic evaluation of hepatitis B immunization strategy among newborns in Shandong. [dissertation\/master\u2019s thesis]. Jinan, China: Shandong University. 2013. [in Chinese]."},{"issue":"7","key":"745_CR41","first-page":"5","volume":"52","author":"P Sun","year":"2018","unstructured":"Sun P, Zhang S. Economic evaluation and prediction of hepatitis B immunization strategy in Shenzhen, China. Chin J Prev Med. 2018;52(7):5. [in Chinese].","journal-title":"Chin J Prev Med"},{"key":"745_CR42","unstructured":"Yu W. Cost\u2013benefit analysis of immunization strategy of newborns hepatitis B vaccine in Shijiazhuang. [dissertation\/master\u2019s thesis]. Shijiazhuang, China: Hebei Medical University. 2004. [in Chinese]."},{"key":"745_CR43","first-page":"534","volume":"5","author":"X Miao","year":"2008","unstructured":"Miao X, Lin Y, Qian Y, Dong M, Gu J, Shi P. Analysis of the effectiveness and cost\u2013effectiveness of hepatitis B vaccine immunization for newborns in Wuxi City. Chin Public Health Manag. 2008;5:534\u20136. [in Chinese].","journal-title":"Chin Public Health Manag"},{"key":"745_CR44","first-page":"208","volume":"2","author":"Z Chen","year":"2008","unstructured":"Chen Z. Cost\u2013effectiveness evaluation of neonatal hepatitis B vaccine immunization. J Bengbu Med Coll. 2008;2:208\u20139. [in Chinese].","journal-title":"J Bengbu Med Coll"},{"key":"745_CR45","unstructured":"Liang S. Decision-making and cost\u2013benefit analysis of hepatitis B immunization among newborns in China. [dissertation\/master\u2019s thesis]. Zhengzhou, China: Zhengzhou University. 2011. [in Chinese]."},{"key":"745_CR46","first-page":"81","volume":"2","author":"Z Liu","year":"1995","unstructured":"Liu Z, Zhao S, Zhang Y, Ma M, Wang H. Cost\u2013benefit analysis on immunization of newborns with hepatitis B vaccine in Jinan City. Chin J Epidemiol. 1995;2:81\u20134. [in Chinese].","journal-title":"Chin J Epidemiol"},{"issue":"14","key":"745_CR47","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/j.vaccine.2013.01.020","volume":"31","author":"SQ Lu","year":"2013","unstructured":"Lu SQ, McGhee SM, Xie X, Cheng J, Fielding R. Economic evaluation of universal newborn hepatitis B vaccination in China. Vaccine. 2013;31(14):1864\u20139.","journal-title":"Vaccine"},{"key":"745_CR48","unstructured":"Guo Y. Cost\u2013utility analysis of the hepatitis B vaccination immunization program for newborns in Beijing from 1992 to 2013. [dissertation\/master\u2019s thesis]. Beijing, China: Beijing University of Chinese Medicine. 2020. [in Chinese]."},{"issue":"6","key":"745_CR49","first-page":"74","volume":"31","author":"L Si","year":"2012","unstructured":"Si L, Jiang Q. Cost\u2013effective analysis of a catch-up hepatitis B vaccination among the children in China. Chin Health Econ. 2012;31(6):74\u20136. [in Chinese].","journal-title":"Chin Health Econ"},{"issue":"7","key":"745_CR50","first-page":"852","volume":"38","author":"Y Lin","year":"2017","unstructured":"Lin Y, Zhang S, Yang P, Cai Y. Cost\u2013effectiveness and affordability of strategy for preventing mother-to-child transmission of hepatitis B in China. Chin J Epidemiol. 2017;38(7):852\u20139. [in Chinese].","journal-title":"Chin J Epidemiol"},{"issue":"17","key":"745_CR51","first-page":"3147","volume":"45","author":"L Zhang","year":"2018","unstructured":"Zhang L, Feng J, Guan Q, Liu M, Zhao S, Liu C. Cost\u2013effectiveness analysis on the immunization strategy of hepatitis B vaccine, Guizhou. Mod Prev Med. 2018;45(17):3147\u201350. [in Chinese].","journal-title":"Mod Prev Med"},{"key":"745_CR52","unstructured":"Sun P. The economic outcomes of national hepatitis B vaccination program forecasted based on decision analytic-Markov model. [dissertation\/master\u2019s thesis]. Guangzhou, China: Guangdong Pharmaceutical University. 2017. [in Chinese]."},{"issue":"8","key":"745_CR53","first-page":"56","volume":"38","author":"L Ye","year":"2019","unstructured":"Ye L, Fang T, Ma R, Lin H, Dong H, Xu G. Health economic evaluation on hepatitis B vaccination introduced into National expanded programme on immunization in Ningbo. Chin Health Econ. 2019;38(8):56\u20139. [in Chinese].","journal-title":"Chin Health Econ"},{"key":"745_CR54","unstructured":"Cai Y. Economic evaluation of preventing for mother-to-child transmission of hepatitis B virus and prophylactic entecavir use for community-based population in Shenzhen. [dissertation\/master\u2019s thesis]. Zhengzhou, China: Zhengzhou University. 2016. [in Chinese]."},{"issue":"5","key":"745_CR55","first-page":"447","volume":"16","author":"X Guan","year":"2010","unstructured":"Guan X, Yang C, Wang J, Yang R, Wu X, Liao A, Xu K, Ju H, Liu Q. The impact and health economic evaluation of hepatitis B vaccination for the infant population in Sichuan Province. Chin J Vaccines Immun. 2010;16(5):447\u201352. [in Chinese].","journal-title":"Chin J Vaccines Immun"},{"issue":"2","key":"745_CR56","first-page":"89","volume":"27","author":"H He","year":"2014","unstructured":"He H, Zhao Y, Chen J, Wu W, Li C, Shan A. Cost\u2013effect analysis of the immunization strategy of infant hepatitis B vaccination implemented in Tianjin from 1992 to 2010. Infect Dis Info. 2014;27(2):89\u201392. [in Chinese].","journal-title":"Infect Dis Info"},{"key":"745_CR57","first-page":"39","volume":"27","author":"Y Liu","year":"2012","unstructured":"Liu Y, He W. Analysis of the cost\u2013effect-benefit of hepatitis B vaccine for infants. Front Med. 2012(27):39-40. [in Chinese].","journal-title":"Front Med"},{"issue":"10","key":"745_CR58","first-page":"6","volume":"29","author":"S Zhang","year":"2008","unstructured":"Zhang S, Dang R, Zhang W, Liang X, Cui J. Analysis on economic efficacy regarding previous strategies and current recommendations for vaccination against hepatitis B virus in China. Chin J Epidemiol. 2008;29(10):6. [in Chinese].","journal-title":"Chin J Epidemiol"},{"issue":"1","key":"745_CR59","first-page":"18","volume":"11","author":"J Li","year":"2011","unstructured":"Li J, Sun L, Zeng X, Fu Z, He J, Pan T, Mo S, Li W. Cost\u2013benefit analysis of hepatitis B vaccine inoculation in infants in Hainan. Chin Trop Med. 2011;11(1):18\u201321. [in Chinese].","journal-title":"Chin Trop Med"},{"issue":"6","key":"745_CR60","first-page":"6","volume":"37","author":"Y Cai","year":"2016","unstructured":"Cai Y, Zhang S, Yang P, Lin J. Cost\u2013effectiveness and cost\u2013benefit analysis on strategy for preventing mother-to-child transmission of hepatitis B virus. Chin J Epidemiol. 2016;37(6):6. [in Chinese].","journal-title":"Chin J Epidemiol"},{"issue":"1","key":"745_CR61","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s40249-022-01032-5","volume":"11","author":"Z Liu","year":"2022","unstructured":"Liu Z, Li M, Hutton DW, Wagner AL, Yao Y, Zhu W, Cao L, Tang S, Pan J, Wang Y, et al. Impact of the National hepatitis B immunization program in china: a modeling study. Infect Dis Poverty. 2022;11(1):106.","journal-title":"Infect Dis Poverty"},{"key":"745_CR62","unstructured":"Lin Y. Cost\u2013effectiveness and affordability of current strategies for hepatitis B vaccination in China. [dissertation\/master\u2019s thesis]. Guangzhou, China: Guangdong Pharmaceutical University. 2016. [in Chinese]."},{"key":"745_CR63","first-page":"22","volume":"6","author":"G Wu","year":"2004","unstructured":"Wu G, Gong Y, Yu S, Shao R, Qin H. Study on the cost\u2013effectiveness, benefit and utility analysis on the infant inoculation hepatitis B vaccine in Shanghai. Chin J Epidemiol. 2004;6:22\u20136. [in Chinese].","journal-title":"Chin J Epidemiol"},{"issue":"3","key":"745_CR64","first-page":"81","volume":"32","author":"B Li","year":"2013","unstructured":"Li B, Cui W, Yi X, Li N, Shi Y. Impact and health economic of hepatitis B vaccination for the infant population in Yantai. Chin Health Econ. 2013;32(3):81\u20133. [in Chinese].","journal-title":"Chin Health Econ"},{"key":"745_CR65","doi-asserted-by":"crossref","unstructured":"Zouch JH, Berg B, Pripp AH, Storheim K, Ashton-James CE, Ferreira ML, Grotle M, Ferreira PH. Reducing strain on primary healthcare systems through innovative models of care: the impact of direct access physiotherapy for musculoskeletal conditions-an interrupted time series analysis. Family Med Community Health. 2024;12(3):e002998.","DOI":"10.1136\/fmch-2024-002998"},{"issue":"1","key":"745_CR66","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40249-024-01192-6","volume":"13","author":"S Chen","year":"2024","unstructured":"Chen S, Rodewald LE, Du AH, Tang S. Advancing the National immunization program in an era of achieving universal vaccine coverage in China and beyond. Infect Dis Poverty. 2024;13(1):25.","journal-title":"Infect Dis Poverty"},{"issue":"7","key":"745_CR67","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1002\/hec.4681","volume":"32","author":"PR Breeze","year":"2023","unstructured":"Breeze PR, Squires H, Ennis K, Meier P, Hayes K, Lomax N, Shiell A, Kee F, de Vocht F, O\u2019Flaherty M, et al. Guidance on the use of complex systems models for economic evaluations of public health interventions. Health Econ. 2023;32(7):1603\u201325.","journal-title":"Health Econ"},{"issue":"12","key":"745_CR68","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2471\/BLT.15.164418","volume":"94","author":"MY Bertram","year":"2016","unstructured":"Bertram MY, Lauer JA, De Joncheere K, Edejer T, Hutubessy R, Kieny MP, Hill SR. Cost-effectiveness thresholds: pros and cons. Bull World Health Organ. 2016;94(12):925\u201330.","journal-title":"Bull World Health Organ"},{"issue":"6","key":"745_CR69","doi-asserted-by":"publisher","first-page":"e000964","DOI":"10.1136\/bmjgh-2018-000964","volume":"3","author":"J Ochalek","year":"2018","unstructured":"Ochalek J, Lomas J, Claxton K. Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data. BMJ Global Health. 2018;3(6):e000964.","journal-title":"BMJ Global Health"}],"container-title":["Health Economics Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13561-026-00745-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13561-026-00745-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13561-026-00745-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T18:03:53Z","timestamp":1774289033000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13561-026-00745-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["745"],"URL":"https:\/\/doi.org\/10.1186\/s13561-026-00745-9","relation":{},"ISSN":["2191-1991"],"issn-type":[{"value":"2191-1991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}